1. Home
  2. ABEO vs RITR Comparison

ABEO vs RITR Comparison

Compare ABEO & RITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • RITR
  • Stock Information
  • Founded
  • ABEO 1974
  • RITR 2015
  • Country
  • ABEO United States
  • RITR Hong Kong
  • Employees
  • ABEO N/A
  • RITR N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • RITR
  • Sector
  • ABEO Health Care
  • RITR
  • Exchange
  • ABEO Nasdaq
  • RITR NYSE
  • Market Cap
  • ABEO 256.9M
  • RITR 221.1M
  • IPO Year
  • ABEO 1980
  • RITR 2024
  • Fundamental
  • Price
  • ABEO $6.59
  • RITR $3.82
  • Analyst Decision
  • ABEO Strong Buy
  • RITR
  • Analyst Count
  • ABEO 6
  • RITR 0
  • Target Price
  • ABEO $18.00
  • RITR N/A
  • AVG Volume (30 Days)
  • ABEO 1.2M
  • RITR 915.8K
  • Earning Date
  • ABEO 08-11-2025
  • RITR 02-15-2025
  • Dividend Yield
  • ABEO N/A
  • RITR N/A
  • EPS Growth
  • ABEO N/A
  • RITR N/A
  • EPS
  • ABEO N/A
  • RITR 0.09
  • Revenue
  • ABEO N/A
  • RITR $47,948,887.00
  • Revenue This Year
  • ABEO N/A
  • RITR N/A
  • Revenue Next Year
  • ABEO $322.37
  • RITR N/A
  • P/E Ratio
  • ABEO N/A
  • RITR $58.64
  • Revenue Growth
  • ABEO N/A
  • RITR 278.44
  • 52 Week Low
  • ABEO $3.93
  • RITR $2.24
  • 52 Week High
  • ABEO $7.32
  • RITR $8.75
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 66.16
  • RITR N/A
  • Support Level
  • ABEO $5.66
  • RITR N/A
  • Resistance Level
  • ABEO $5.99
  • RITR N/A
  • Average True Range (ATR)
  • ABEO 0.26
  • RITR 0.00
  • MACD
  • ABEO 0.09
  • RITR 0.00
  • Stochastic Oscillator
  • ABEO 76.92
  • RITR 0.00

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About RITR REITAR LOGTECH HLDGS LTD

Reitar Logtech Holdings Ltd provide one-stop solutions for logistics property operations in property development and redevelopment projects. It consists of two segments: construction management and engineering design services; and asset management and professional consultancy services in Hong Kong. Key revenue is generated from construction management and engineering design services.

Share on Social Networks: